MSON Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 Jan 1970 @ 01:00):

Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets minimally invasive surgical ultrasonic medical devices in the United States and internationally...

Stats
Tagesvolumen	157 169
Durchschnittsvolumen	57 194.00
Marktkapitalisierung	0.00
EPS	$-0.260 ( 2021-09-15 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.641 (2.42%)

Insider Trading

Date	Person	Action	Amount	type
2021-10-29	Vizirgianakis Stavros G.	Sell	2 136 478	Common Stock
2021-10-29	Patton Thomas M	Sell	104 500	Common Stock
2021-10-29	Laviolette Paul A	Sell	1 744 017	Common Stock
2021-10-29	Dwyer Joseph P	Sell	276 200	Common Stock
2021-06-30	Waggoner Jonathan Jay	Buy	15 000	Stock Option

INSIDER POWER
0.00
Last 98 transactions
Buy: 1 378 801 \| Sell: 4 339 021

Volumen Korrelation

Lang: 0.25 (neutral)

Kurz: 0.60 (weak)

Signal:(63.159) Neutral

Misonix Inc Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Misonix Inc Korrelation - Währung/Rohstoff

-0.63
( weak negative )

0.15
( neutral )

0.28
( neutral )

-0.28
( neutral )

-0.36
( neutral )

0.57
( weak )

Misonix Inc Finanzdaten

Annual	2021
Umsatz:	$74.02M
Bruttogewinn:	$52.64M (71.11 %)
EPS:	$-0.987

FY	2021
Umsatz:	$74.02M
Bruttogewinn:	$52.64M (71.11 %)
EPS:	$-0.987

FY	2020
Umsatz:	$62.48M
Bruttogewinn:	$43.71M (69.95 %)
EPS:	$-1.190

FY	2019
Umsatz:	$38.85M
Bruttogewinn:	$27.28M (70.22 %)
EPS:	$-0.790

Financial Reports:

No articles found.

Misonix Inc

Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets minimally invasive surgical ultrasonic medical devices in the United States and internationally. The company's products include BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, general surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.